These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8996599)

  • 1. Clinical development of topoisomerase-interactive drugs.
    Muggia FM; Burris HA
    Adv Pharmacol; 1994; 29B():1-31. PubMed ID: 8996599
    [No Abstract]   [Full Text] [Related]  

  • 2. Topoisomerase inhibitors. A review of their therapeutic potential in cancer.
    Sinha BK
    Drugs; 1995 Jan; 49(1):11-9. PubMed ID: 7705211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of camptothecin analogs in childhood cancers.
    Bomgaars L; Berg SL; Blaney SM
    Oncologist; 2001; 6(6):506-16. PubMed ID: 11743213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.
    Hartmann JT; Lipp HP
    Drug Saf; 2006; 29(3):209-30. PubMed ID: 16524321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of topoisomerase I-targeting agents.
    Arbuck SG; Takimoto CH
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):3-12. PubMed ID: 9779876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of topoisomerases I and II--is this a worthwhile/feasible strategy?
    Vasey PA; Kaye SB
    Br J Cancer; 1997; 76(11):1395-7. PubMed ID: 9400932
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA topoisomerase I inhibitors.
    Takimoto CH; Kieffer LV; Arbuck SG
    Cancer Chemother Biol Response Modif; 1997; 17():80-113. PubMed ID: 9551210
    [No Abstract]   [Full Text] [Related]  

  • 8. Topoisomerase I inhibitors: review and update.
    Rothenberg ML
    Ann Oncol; 1997 Sep; 8(9):837-55. PubMed ID: 9358934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase I inhibitors in the treatment of colorectal cancer.
    Rothenberg ML; Blanke CD
    Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of topoisomerase I inhibitors in anticancer treatment.
    Rodriguez-Galindo C; Radomski K; Stewart CF; Furman W; Santana VM; Houghton PJ
    Med Pediatr Oncol; 2000 Oct; 35(4):385-402. PubMed ID: 11025469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topoisomerase I inhibitors. Review of phase II trials with irinotecan (CPT-11) and topotecan].
    Bonneterre J
    Bull Cancer; 1995 Aug; 82(8):623-8. PubMed ID: 7492818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting topotecan sensitivity in human leukemia samples.
    Kaufmann SH; Gore SD; Letendre L; Svingen PA; Kottke T; Buckwalter CA; Jones RJ; Grochow LB; Burke PJ; Donehower RC; Rowinsky EK
    Ann N Y Acad Sci; 1996 Dec; 803():128-42. PubMed ID: 8993506
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer chemotherapy: irinotecan.
    Rougier P; Mitry E
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):138-43. PubMed ID: 11049046
    [No Abstract]   [Full Text] [Related]  

  • 14. [A symphony for the camptothecins].
    Lansiaux A; Bailly C
    Bull Cancer; 2003 Mar; 90(3):239-45. PubMed ID: 12801826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation.
    Lamond JP; Mehta MP; Boothman DA
    J Neurooncol; 1996 Oct; 30(1):1-6. PubMed ID: 8864997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase I inhibitors: topotecan and irenotecan.
    Creemers GJ; Lund B; Verweij J
    Cancer Treat Rev; 1994 Jan; 20(1):73-96. PubMed ID: 8293429
    [No Abstract]   [Full Text] [Related]  

  • 17. Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.
    Gerrits CJ; de Jonge MJ; Schellens JH; Stoter G; Verweij J
    Br J Cancer; 1997; 76(7):952-62. PubMed ID: 9328159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with the topoisomerase I inhibitors.
    Burris HA; Rothenberg ML; Kuhn JG; Von Hoff DD
    Semin Oncol; 1992 Dec; 19(6):663-9. PubMed ID: 1334279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase-I inhibitors in the management of colon cancer.
    Willson JK
    Ann N Y Acad Sci; 1996 Dec; 803():256-63. PubMed ID: 8993519
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolving role of irinotecan: a broad-spectrum chemotherapeutic agent. Introduction.
    Ajani JA
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):17-8. PubMed ID: 11200142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.